[1]
Masao Sugamata 2021. A Critical Discussion: Possibility of the Strategic Treatment for Various Tumors Using the Leukotriene Receptor Antagonist Based on the Common Pathologic Findings that Mast Cells and Leukotrienes are Involved in the Development and Proliferation of Tumors. Current Topics in Medicine and Medical Research Vol. 13. (Apr. 2021), 13–18. DOI:https://doi.org/10.9734/bpi/ctmmr/v13/6645D.